Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Free Cash Flow (Quarterly): -17.36M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -17.36M |
September 30, 2023 | -25.54M |
June 30, 2023 | -29.41M |
March 31, 2023 | -27.73M |
December 31, 2022 | -23.84M |
September 30, 2022 | -20.72M |
June 30, 2022 | -24.09M |
March 31, 2022 | -23.10M |
Date | Value |
---|---|
December 31, 2021 | -23.22M |
September 30, 2021 | -17.67M |
June 30, 2021 | -17.49M |
March 31, 2021 | -13.45M |
December 31, 2020 | -13.71M |
September 30, 2020 | -8.248M |
June 30, 2020 | -5.813M |
March 31, 2020 | -2.703M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-29.41M
Minimum
Jun 2023
-2.703M
Maximum
Mar 2020
-18.38M
Average
-19.20M
Median
Free Cash Flow (Quarterly) Benchmarks
XOMA Corp | -4.964M |
Societal CDMO Inc (DELISTED) | 0.793M |
NGM Biopharmaceuticals Inc (DELISTED) | -23.15M |
Avrobio Inc | -7.569M |
Landos Biopharma Inc | -8.498M |